December 01, 2017
Publication of Cannabis Investment Report
| Name | Type | Mentions | |
|---|---|---|---|
| Ackrell Capital | person | 2 | View Entity |
HOUSE_OVERSIGHT_024654.jpg
This document is page 18 of a 'Cannabis Investment Report' published by Ackrell Capital, LLC in December 2017. It provides a scientific overview of the Human Endocannabinoid System, specifically detailing the functions and locations of CB1 and CB2 receptors in the body. It bears the Bates stamp 'HOUSE_OVERSIGHT_024654', indicating it was part of a document production for a congressional investigation, though the specific page contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024730.jpg
This document is page 94 of a 'Cannabis Investment Report' published by Ackrell Capital in December 2017. It provides a detailed regulatory analysis of United Nations drug control conventions (1961, 1971, and 1988) regarding the scheduling and prohibition of substances like THC and cannabis. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024730', indicating it was part of a document production to the House Oversight Committee, likely during an investigation involving financial records or investments.
HOUSE_OVERSIGHT_024740.jpg
This document is page 104 of a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It analyzes market trends, including the medical efficacy of cannabis, the increase in recreational legalization (citing Uruguay, Canada, and US states like Colorado and California), product innovation, and pricing dynamics between legal and illegal markets. The document bears a 'HOUSE_OVERSIGHT_024740' stamp, indicating it was part of a document production for a Congressional investigation, though the text itself contains no direct references to Jeffrey Epstein or specific individuals.
Events with shared participants
Publication of the Cannabis Investment Report.
2017-12-01 • United States
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event